3043 related articles for article (PubMed ID: 7738369)
1. Ras gene mutations: a rare event in nonmetastatic primary malignant melanoma.
Wagner SN; Ockenfels HM; Wagner C; Höfler H; Goos M
J Invest Dermatol; 1995 May; 104(5):868-71. PubMed ID: 7738369
[TBL] [Abstract][Full Text] [Related]
2. Ras mutations in human melanoma: a marker of malignant progression.
Ball NJ; Yohn JJ; Morelli JG; Norris DA; Golitz LE; Hoeffler JP
J Invest Dermatol; 1994 Mar; 102(3):285-90. PubMed ID: 8120410
[TBL] [Abstract][Full Text] [Related]
3. Point mutations in the N-ras oncogene in malignant melanoma and congenital naevi.
Carr J; Mackie RM
Br J Dermatol; 1994 Jul; 131(1):72-7. PubMed ID: 8043423
[TBL] [Abstract][Full Text] [Related]
4. Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma.
van Elsas A; Zerp SF; van der Flier S; Krüse KM; Aarnoudse C; Hayward NK; Ruiter DJ; Schrier PI
Am J Pathol; 1996 Sep; 149(3):883-93. PubMed ID: 8780392
[TBL] [Abstract][Full Text] [Related]
5. Analysis of ras mutations in human melanocytic lesions: activation of the ras gene seems to be associated with the nodular type of human malignant melanoma.
Jafari M; Papp T; Kirchner S; Diener U; Henschler D; Burg G; Schiffmann D
J Cancer Res Clin Oncol; 1995; 121(1):23-30. PubMed ID: 7860615
[TBL] [Abstract][Full Text] [Related]
6. N-ras mutations are common in melanomas from sun-exposed skin of humans but rare in mucosal membranes or unexposed skin.
Jiveskog S; Ragnarsson-Olding B; Platz A; Ringborg U
J Invest Dermatol; 1998 Nov; 111(5):757-61. PubMed ID: 9804334
[TBL] [Abstract][Full Text] [Related]
7. The role of UV-radiation in the development of conjunctival malignant melanoma.
El-Shabrawi Y; Radner H; Muellner K; Langmann G; Hoefler G
Acta Ophthalmol Scand; 1999 Feb; 77(1):31-2. PubMed ID: 10071144
[TBL] [Abstract][Full Text] [Related]
8. Absence of ras gene mutations in UV-induced malignant melanomas correlates with a dermal origin of melanocytes in Monodelphis domestica.
Chan J; Robinson ES; Yeh IT; McCarrey JR
Cancer Lett; 2002 Oct; 184(1):73-80. PubMed ID: 12104050
[TBL] [Abstract][Full Text] [Related]
9. Polymerase chain reaction/sequencing analysis of ras mutations in paraffin-embedded tissues as compared with 3T3 transfection and polymerase chain reaction/sequencing of frozen tumor deoxyribonucleic acids.
Goodrow TL; Prahalada SR; Storer RD; Manam SV; Leander KR; Kraynak AR; van Zwieten MJ; Nichols WW; Bradley MO
Lab Invest; 1992 Apr; 66(4):504-11. PubMed ID: 1583889
[TBL] [Abstract][Full Text] [Related]
10. Analysis of ras oncogenes in malignant melanoma and precursor lesions: correlation of point mutations with differentiation phenotype.
Albino AP; Nanus DM; Mentle IR; Cordon-Cardo C; McNutt NS; Bressler J; Andreeff M
Oncogene; 1989 Nov; 4(11):1363-74. PubMed ID: 2682463
[TBL] [Abstract][Full Text] [Related]
11. Screening of N-ras codon 61 mutations in paired primary and metastatic cutaneous melanomas: mutations occur early and persist throughout tumor progression.
Omholt K; Karsberg S; Platz A; Kanter L; Ringborg U; Hansson J
Clin Cancer Res; 2002 Nov; 8(11):3468-74. PubMed ID: 12429636
[TBL] [Abstract][Full Text] [Related]
12. Lack of evidence of Ki-ras codon 12 mutations in melanocytic lesions.
Albino AP; Nanus DM; Davis ML; McNutt NS
J Cutan Pathol; 1991 Aug; 18(4):273-8. PubMed ID: 1939786
[TBL] [Abstract][Full Text] [Related]
13. TTC4, a novel candidate tumor suppressor gene at 1p31 is often mutated in malignant melanoma of the skin.
Poetsch M; Dittberner T; Cowell JK; Woenckhaus C
Oncogene; 2000 Nov; 19(50):5817-20. PubMed ID: 11126369
[TBL] [Abstract][Full Text] [Related]
14. BRAF and NRAS mutations in melanoma and melanocytic nevi.
Poynter JN; Elder JT; Fullen DR; Nair RP; Soengas MS; Johnson TM; Redman B; Thomas NE; Gruber SB
Melanoma Res; 2006 Aug; 16(4):267-73. PubMed ID: 16845322
[TBL] [Abstract][Full Text] [Related]
15. Activating BRAF and N-Ras mutations in sporadic primary melanomas: an inverse association with allelic loss on chromosome 9.
Kumar R; Angelini S; Hemminki K
Oncogene; 2003 Dec; 22(58):9217-24. PubMed ID: 14681681
[TBL] [Abstract][Full Text] [Related]
16. Detection of B-RAF and N-RAS mutations in human melanoma.
Goydos JS; Mann B; Kim HJ; Gabriel EM; Alsina J; Germino FJ; Shih W; Gorski DH
J Am Coll Surg; 2005 Mar; 200(3):362-70. PubMed ID: 15737846
[TBL] [Abstract][Full Text] [Related]
17. A novel N-ras mutation in malignant melanoma is associated with excellent prognosis.
Demunter A; Ahmadian MR; Libbrecht L; Stas M; Baens M; Scheffzek K; Degreef H; De Wolf-Peeters C; van Den Oord JJ
Cancer Res; 2001 Jun; 61(12):4916-22. PubMed ID: 11406571
[TBL] [Abstract][Full Text] [Related]
18. Investigation of the role of the ras protooncogene point mutation in human uveal melanomas.
Soparker CN; O'Brien JM; Albert DM
Invest Ophthalmol Vis Sci; 1993 Jun; 34(7):2203-9. PubMed ID: 8505202
[TBL] [Abstract][Full Text] [Related]
19. Analysis of N- and K-ras mutations in the distinctive tumor progression phases of melanoma.
Demunter A; Stas M; Degreef H; De Wolf-Peeters C; van den Oord JJ
J Invest Dermatol; 2001 Dec; 117(6):1483-9. PubMed ID: 11886512
[TBL] [Abstract][Full Text] [Related]
20. Codon 12 Harvey-ras mutations are rare events in non-melanoma human skin cancer.
Campbell C; Quinn AG; Rees JL
Br J Dermatol; 1993 Feb; 128(2):111-4. PubMed ID: 8096149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
